According to a new report by UnivDatos, the Premenstrual Syndrome Treatment Market is expected to reach USD million in 2033 by growing at a CAGR of 4.74%. Key Highlights of the Report: Ø The increasing prevalence of premenstrual syndrome (PMS) due to lifestyle changes, elevated stress, poor diet, and hormonal imbalances is driving the global premenstrual syndrome treatment market....

According to UnivDatos analysis, rising global awareness and diagnosis of women’s health issues, increasing adoption of digital health platforms, coupled with rising mergers and acquisitions, are the major factors driving the growth of the premenstrual syndrome treatment market. As per their “Premenstrual Syndrome Treatment Market” report, the global market was valued at USD...